位置:首页 > 蛋白库 > LTP2_THECD
LTP2_THECD
ID   LTP2_THECD              Reviewed;         391 AA.
AC   D1AB74;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   19-JAN-2010, sequence version 1.
DT   25-MAY-2022, entry version 55.
DE   RecName: Full=Steroid side-chain-cleaving aldolase {ECO:0000305};
DE            EC=4.1.3.- {ECO:0000269|PubMed:31209106};
DE   AltName: Full=3-oxo-23,24-bisnorchol-4-en-17-ol-22-oyl-CoA lyase {ECO:0000305};
GN   Name=ltp2 {ECO:0000303|PubMed:31209106};
GN   OrderedLocusNames=Tcur_3479 {ECO:0000312|EMBL:ACY99017.1};
OS   Thermomonospora curvata (strain ATCC 19995 / DSM 43183 / JCM 3096 / KCTC
OS   9072 / NBRC 15933 / NCIMB 10081 / Henssen B9).
OC   Bacteria; Actinobacteria; Streptosporangiales; Thermomonosporaceae;
OC   Thermomonospora.
OX   NCBI_TaxID=471852;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 19995 / DSM 43183 / JCM 3096 / KCTC 9072 / NBRC 15933 / NCIMB
RC   10081 / Henssen B9;
RX   PubMed=21475583; DOI=10.4056/sigs.1453580;
RA   Chertkov O., Sikorski J., Nolan M., Lapidus A., Lucas S., Del Rio T.G.,
RA   Tice H., Cheng J.F., Goodwin L., Pitluck S., Liolios K., Ivanova N.,
RA   Mavromatis K., Mikhailova N., Ovchinnikova G., Pati A., Chen A.,
RA   Palaniappan K., Djao O.D., Land M., Hauser L., Chang Y.J., Jeffries C.D.,
RA   Brettin T., Han C., Detter J.C., Rohde M., Goeker M., Woyke T., Bristow J.,
RA   Eisen J.A., Markowitz V., Hugenholtz P., Klenk H.P., Kyrpides N.C.;
RT   "Complete genome sequence of Thermomonospora curvata type strain (B9).";
RL   Stand. Genomic Sci. 1:13-22(2011).
RN   [2] {ECO:0007744|PDB:6OK1}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH CHSH2-DUF35,
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   INTERACTION WITH CHSH2, ACTIVE SITE, AND MUTAGENESIS OF GLY-82; TYR-294;
RP   HIS-296; TYR-344 AND HIS-346.
RC   STRAIN=ATCC 19995 / DSM 43183 / JCM 3096 / KCTC 9072 / NBRC 15933 / NCIMB
RC   10081 / Henssen B9;
RX   PubMed=31209106; DOI=10.1074/jbc.ra119.008889;
RA   Aggett R., Mallette E., Gilbert S.E., Vachon M.A., Schroeter K.L.,
RA   Kimber M.S., Seah S.Y.K.;
RT   "The steroid side-chain-cleaving aldolase Ltp2-ChsH2DUF35 is a thiolase
RT   superfamily member with a radically repurposed active site.";
RL   J. Biol. Chem. 294:11934-11943(2019).
CC   -!- FUNCTION: Probably involved in bile acid degradation (Probable). In
CC       vitro, when associated with the ChsH1/ChsH2 hydratase, catalyzes the
CC       retroaldol cleavage of 17-hydroxy-3-oxo-4-pregnene-20-carboxyl-CoA (17-
CC       HOPC-CoA), forming androst-4-ene-3,17-dione and propionyl-CoA
CC       (PubMed:31209106). The in vivo substrate is probably a closely
CC       analogous bile acid degradation metabolite (Probable).
CC       {ECO:0000269|PubMed:31209106, ECO:0000305|PubMed:31209106}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17-hydroxy-3-oxochol-4-en-22-oyl-CoA = androst-4-ene-3,17-
CC         dione + propanoyl-CoA; Xref=Rhea:RHEA:46648, ChEBI:CHEBI:16422,
CC         ChEBI:CHEBI:57392, ChEBI:CHEBI:86028;
CC         Evidence={ECO:0000269|PubMed:31209106};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.4 uM for 17-HOPC-CoA (in the presence of ChsH2-DUF35)
CC         {ECO:0000269|PubMed:31209106};
CC         Note=kcat is 7.1 sec(-1). {ECO:0000269|PubMed:31209106};
CC   -!- SUBUNIT: Homodimer (PubMed:31209106). Interacts with the ChsH1/ChsH2
CC       hydratase via the DUF35 C-terminal region of ChsH2 (ChsH2-DUF35)
CC       (PubMed:31209106). {ECO:0000269|PubMed:31209106}.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001738; ACY99017.1; -; Genomic_DNA.
DR   RefSeq; WP_012853801.1; NC_013510.1.
DR   PDB; 6OK1; X-ray; 1.70 A; A/C=1-391.
DR   PDBsum; 6OK1; -.
DR   AlphaFoldDB; D1AB74; -.
DR   SMR; D1AB74; -.
DR   STRING; 471852.Tcur_3479; -.
DR   EnsemblBacteria; ACY99017; ACY99017; Tcur_3479.
DR   KEGG; tcu:Tcur_3479; -.
DR   eggNOG; COG0183; Bacteria.
DR   HOGENOM; CLU_035425_2_0_11; -.
DR   OMA; FMAHYAP; -.
DR   OrthoDB; 647502at2; -.
DR   Proteomes; UP000001918; Chromosome.
DR   GO; GO:0016747; F:acyltransferase activity, transferring groups other than amino-acyl groups; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.47.10; -; 1.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   PIRSF; PIRSF000429; Ac-CoA_Ac_transf; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Bile acid catabolism; Lipid degradation; Lipid metabolism;
KW   Lyase; Reference proteome; Steroid metabolism.
FT   CHAIN           1..391
FT                   /note="Steroid side-chain-cleaving aldolase"
FT                   /id="PRO_0000452244"
FT   ACT_SITE        294
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:31209106"
FT   ACT_SITE        344
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:31209106"
FT   MUTAGEN         82
FT                   /note="G->P: Almost loss of activity."
FT                   /evidence="ECO:0000269|PubMed:31209106"
FT   MUTAGEN         294
FT                   /note="Y->F: Almost loss of activity. Loss of activity;
FT                   when associated with F-344."
FT                   /evidence="ECO:0000269|PubMed:31209106"
FT   MUTAGEN         296
FT                   /note="H->A: 13-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:31209106"
FT   MUTAGEN         344
FT                   /note="Y->F: 322-fold decrease in catalytic efficiency.
FT                   Loss of activity; when associated with F-294."
FT                   /evidence="ECO:0000269|PubMed:31209106"
FT   MUTAGEN         346
FT                   /note="H->A: 11-fold decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:31209106"
FT   TURN            5..7
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          8..15
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           26..40
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          50..54
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           61..68
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          73..79
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           82..85
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           86..98
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          103..112
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   TURN            113..115
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           132..135
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           148..163
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           167..182
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   TURN            188..191
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           196..201
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           211..213
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          219..228
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           229..232
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          235..237
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          240..249
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           268..281
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           301..307
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           316..321
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   TURN            322..325
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           338..341
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   HELIX           348..359
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          370..375
FT                   /evidence="ECO:0007829|PDB:6OK1"
FT   STRAND          378..388
FT                   /evidence="ECO:0007829|PDB:6OK1"
SQ   SEQUENCE   391 AA;  41404 MW;  FEE8D313CF0D8894 CRC64;
     MSVLPGAAAI AGIGATEFSK NSGRSELQLA CEAVLAAIAD AGLEPSDVDG LVTFTADTSS
     EIHVARNTGI GELKFFSRVG YGGGAACGTV QQAAMAVATG IAEVVVCYRA FNERSGVRYG
     LGQAGRQMDQ GADSAAYAWL LPFGLNTPAQ WVAMFARRYM HEYGATSEDF GRVAVVDRKH
     AATNPKAWFY QRPITLEDHQ NSRWIVEPLH LLDCCQESDG GQALVVVSTE RARDLPHPPA
     LIWGAAQGSG YDQHMMTSYY RSEITGIPEM GLVGQQLYAQ SGLNPSDIGA AILYDHFTPL
     VLPQLEELGF CARGEAKDFI ADGNLEIGGR LPCNTHGGQL GEAYIHGMNG IAEAVRLVRG
     TSVNQPGDVT NVLVTAGTGV PTSGLILGAD R
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024